Neogen | NEOG - Current Assets


Neogen reported $590M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Agilent USD 4.76B 148M Mar/2026
Avanos Medical USD 325M 30.4M Mar/2026
Bio-Rad Laboratories USD 2.94B 35.9M Mar/2026
Cerus USD 174.38M 7.26M Dec/2025
Danaher USD 13.94B 1.18B Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
Illumina USD 2.74B 551M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Neogen USD 590M 15.42M Dec/2025
OraSure Technologies USD 240.78M 21.13M Mar/2026
Pacific Biosciences Of California USD 369.52M 5.54M Mar/2026
Quidel USD 1.38B 70.3M Mar/2026
Rockwell Medical USD 31.61M 1.42M Jun/2025
STAAR Surgical USD 312.4M 853K Mar/2026
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Utah Medical Products USD 97.74M 1.21M Dec/2025
Zoetis USD 6.47B 294M Mar/2026